Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: GENENTECH USA, INC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2024-09-30 to 2025-09-29
Current total value of award: $21999906.94
Description: XOFLUZA (BALOXAVIR MARBOXIL)